View in EDS HTML Full Text PDF Full Text

The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited.

Saved in:
Bibliographic Details
Title: The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited.
Authors: Domenighetti C; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Team 'Exposome, Heredity, Cancer, and Health', CESP, Villejuif, France., Douillard V; Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, Nantes, France., Sugier PE; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Team 'Exposome, Heredity, Cancer, and Health', CESP, Villejuif, France., Sreelatha AAK; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology, and Applied Biometry, University of Tubingen, Tübingen, Germany., Schulte C; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tubingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tubingen, Germany., Grover S; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology, and Applied Biometry, University of Tubingen, Tübingen, Germany., May P; Translational Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg., Bobbili DR; Translational Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg., Radivojkov-Blagojevic M; Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany., Lichtner P; Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany., Singleton AB; Molecular Genetics Section, Laboratory of Neurogenetics, NIA, NIH, Bethesda, Maryland, USA.; Center For Alzheimer's and Related Dementias, NIA, NIH, Bethesda, Maryland, USA., Hernandez DG; Molecular Genetics Section, Laboratory of Neurogenetics, NIA, NIH, Bethesda, Maryland, USA., Edsall C; Molecular Genetics Section, Laboratory of Neurogenetics, NIA, NIH, Bethesda, Maryland, USA., Gourraud PA; Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, Nantes, France., Mellick GD; Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia., Zimprich A; Department of Neurology, Medical University of Vienna, Wien, Austria., Pirker W; Department of Neurology, Klinik Ottakring, Vienna, Austria., Rogaeva E; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada., Lang AE; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada.; Division of Neurology, University of Toronto, Toronto, Ontario, Canada.; Krembil Brain Institute, Toronto, Ontario, Canada., Koks S; Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Murdoch, Australia.; Perron Institute for Neurological and Translational Science, Nedlands, Western Australia, Australia., Taba P; Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.; Neurology Clinic, Tartu University Hospital, Tartu, Estonia., Lesage S; Department of Neurologie, Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, Assistance Publique Hôpitaux de Paris, Paris, France., Brice A; Department of Neurologie, Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, Assistance Publique Hôpitaux de Paris, Paris, France., Corvol JC; Department of Neurologie, Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, Assistance Publique Hôpitaux de Paris, Paris, France.; Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Paris, France., Chartier-Harlin MC; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog- Centre de Recherche Lille Neurosciences and Cognition, Lille, France., Mutez E; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog- Centre de Recherche Lille Neurosciences and Cognition, Lille, France., Brockmann K; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tubingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tubingen, Germany., Deutschländer AB; Department of Neurology, Ludwig Maximilians University of Munich, Munich, Germany.; Department of Neurology, Max Planck Institute of Psychiatry, Munich, Germany.; Department of Neurology and Department of Clinical Genomics, Mayo Clinic Florida, Jacksonville, Florida, USA., Hadjigeorgiou GM; Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece.; Department of Neurology, Medical School, University of Cyprus, Nicosia, Cyprus., Dardiotis E; Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece., Stefanis L; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.; Center of Clinical Research, Experimental Surgery, and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece., Simitsi AM; 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Valente EM; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Mondino Foundation, Pavia, Italy., Petrucci S; UOC Medical Genetics and Advanced Cell Diagnostics, S. Andrea University Hospital, Rome, Italy.; Department of Clinical and Molecular Medicine, University of Rome, Rome, Italy., Duga S; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Humanitas Clinical and Research Center, IRCCS, Milan, Italy., Straniero L; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Zecchinelli A; Parkinson Institute, Azienda Socio Sanitaria Territoriale (ASST) Gaetano Pini/CTO, Milan, Italy., Pezzoli G; Parkinson Institute, Fontazione Grigioni, Milan, Italy., Brighina L; Department of Neurology, San Gerardo Hospital, Monza, Italy.; Department of Medicine and Surgery and Milan Center for Neuroscience, University of Milano Bicocca, Milan, Italy., Ferrarese C; Department of Neurology, San Gerardo Hospital, Monza, Italy.; Department of Medicine and Surgery and Milan Center for Neuroscience, University of Milano Bicocca, Milan, Italy., Annesi G; Institute for Biomedical Research and Innovation, National Research Council, Cosenza, Italy., Quattrone A; Institute of Neurology, Magna Graecia University, Catanzaro, Italy., Gagliardi M; Institute of Molecular Bioimaging and Physiology National Research Council, Catanzaro, Italy., Matsuo H; Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Saitama, Japan., Nakayama A; Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Saitama, Japan., Hattori N; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan., Nishioka K; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan., Chung SJ; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Kim YJ; Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea., Kolber P; Neurology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg., van de Warrenburg BPC; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands., Bloem BR; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands., Aasly J; Department of Neurology, St Olav's Hospital and Norwegian University of Science and Technology, Trondheim, Norway., Toft M; Department of Neurology, Oslo University Hospital, Oslo, Norway., Pihlstrøm L; Department of Neurology, Oslo University Hospital, Oslo, Norway., Correia Guedes L; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Department of Neurosciences and Mental Health, Neurology, Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN), Lisbon, Portugal., Ferreira JJ; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Bardien S; Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa., Carr J; Division of Neurology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa., Tolosa E; Parkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED: CB06/05/0018-ISCIII) Barcelona, Barcelona, Spain., Ezquerra M; Lab of Parkinson Disease and Other Neurodegenerative Movement Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Institut de Neurociències, Universitat de Barcelona, Barcelona, Catalonia, Spain., Pastor P; Fundació per la Recerca Biomèdica i Social Mútua Terrassa, Barcelona, Spain.; Movement Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, Barcelona, Spain., Diez-Fairen M; Fundació per la Recerca Biomèdica i Social Mútua Terrassa, Barcelona, Spain.; Movement Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, Barcelona, Spain., Wirdefeldt K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Pedersen NL; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Ran C; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden., Belin AC; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden., Puschmann A; Department of Clinical Sciences Lund, Neurology, Lund University, Skåne University Hospital, Lund, Sweden., Ygland Rödström E; Department of Clinical Sciences Lund, Neurology, Lund University, Skåne University Hospital, Lund, Sweden., Clarke CE; University of Birmingham and Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom., Morrison KE; Faculty of Medicine, Health and Life Sciences, Queens University, Belfast, United Kingdom., Tan M; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom., Krainc D; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Burbulla LF; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Farrer MJ; Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA., Krüger R; Translational Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.; Neurology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.; Parkinson's Research Clinic, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.; Transversal Translational Medicine, Luxembourg Institute of Health (LIH), Strassen, Luxembourg., Gasser T; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tubingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tubingen, Germany., Sharma M; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology, and Applied Biometry, University of Tubingen, Tübingen, Germany., Vince N; Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, Nantes, France., Elbaz A; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Team 'Exposome, Heredity, Cancer, and Health', CESP, Villejuif, France.
Corporate Authors: Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (Courage-PD) Consortium
Source: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2022 Sep; Vol. 37 (9), pp. 1929-1937. Date of Electronic Publication: 2022 Jul 10.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1531-8257
DOI:10.1002/mds.29133